India Infusion Pumps Market: By Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA) Pumps, Pump Accessories), By Specialty (Chemotherapy, Gastroenterology, Analgesia/Pain Management, Pediatrics, Neonatology, Hematology, Others), and By End User (Corporate Hospitals, Tier I Hospitals, Tier II Hospitals, Government Hospitals, Others) and Forecast to 2030

India Infusion Pumps Market was valued at US$ 238.1 million in 2023 and is expected to grow at a 6.6% CAGR from 2024 to 2030. The increasing prevalence of surgical procedures in India, estimated at approximately 30 million annually, emphasize the critical role of infusion pumps within the healthcare ecosystem. These india infusion pumps are indispensable devices utilized to deliver medications, fluids, and nutrients to patients during surgical interventions, ensuring precise and controlled administration. Interestingly, the distribution of surgical procedures across different types of healthcare facilities in India highlights the widespread demand for infusion pumps. With 85% of surgeries occurring in smaller and mid-size hospitals, there exists a substantial need for infusion pump technology across a diverse range of healthcare settings. This indicates that india infusion pumps are not only essential in large corporate hospitals but also in smaller healthcare facilities, reflecting the broad spectrum of healthcare needs across the country.

Furthermore, projections based on studies estimating the age-adjusted requirement for surgeries in India suggest a staggering demand for approximately 50 million surgeries annually. This significant volume emphasizes the critical role infusion pumps play in supporting surgical interventions and ensuring optimal patient care outcomes. A recent study indicated an age-adjusted requirement of 3,646 surgeries per 100,000 Indian population annually, with one-third of these surgeries needed for individuals aged 30–49 years. Extrapolating from this study, India's surgical demand is projected to approach nearly 50 million procedures annually, illustrating the substantial need for infusion pumps to support medication administration during surgical interventions. Therefore, the rising demand for infusion pumps in India is intricately linked to the increasing volume of surgical procedures, reflecting the vital role these devices play in supporting surgical interventions. 

Key Developments

• In May 2024, Baxter International Inc. a pioneer in infusion therapies and technologies, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) featuring Dose IQ Safety Software. This clearance marks a pivotal moment for Baxter as it expands the Novum IQ Infusion Platform to include the LVP modality, complementing Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software and powered by the IQ Enterprise Connectivity Suite.
• In December 2023, Fresenius Kabi announced a groundbreaking multiyear agreement with the prestigious Mayo Clinic, signaling a significant milestone in the healthcare industry. Under this agreement, the Mayo Clinic plans to acquire 10,000 units of the innovative Ivenix large-volume infusion pumps for its hospitals and clinics located in Minnesota, Arizona, and Florida.